Mucosal care has long been an unmet need in clinical practice, especially for
cancer patients receiving chemotherapy or radiotherapy, individuals
suffering from virus-related mouth ulcers, and those with autoimmune
diseases that trigger painful mucositis. Current treatments often fail to
provide rapid pain relief and are limited by dosage restrictions.
A Taiwan-based biotech company has developed an innovative mucosal gel
for oral, nasal, and rectal applications to address these challenges. This
breakthrough medical device is designed to relieve pain quickly, protect
sensitive mucosal tissue, and support healing without the limitations of
traditional drug treatments. Hannox is now preparing to share this series of
products with healthcare providers and patients worldwide. For more
information, visit https://www.hannox.com.tw
Founded in 2003, Hannox is a professional healthcare company specializing in
the export of medical devices, pharmaceuticals, and wellness products. The
company has built a global platform in collaboration with experts from the
biotechnology, pharmaceutical, and medical device industries to provide
integrated healthcare solutions.
Hannox’s product portfolio includes active pharmaceutical ingredients (APIs),
home care, baby care, wound care, mucosal care, and dental care products.
Key products range from oral/nasal/rectal mucosal gel, liquid bandages,
blood glucose meters, mosquito repellents, and a wide variety of medical
devices.
With two decades of expertise in pharmaceuticals and medical equipment,
Hannox understands that global partners seek comprehensive solutions
rather than single products. The company offers pharmaceutical formulation
development, medical device OEM/ODM, and distribution. Supported by its
in-house design team, Hannox can deliver customized solutions quickly and
cost-effectively.
Hannox remains committed to innovation, competitiveness, and customer
success. For over 20 years, the company has built trust with clients
worldwide by delivering quality healthcare solutions and expanding its
presence across the global market.
